AmplifyBio’s Post

Optimizing cell culture media is a key success factor necessary for high yield / high titer production processes. When MilliporeSigma started optimizing media across several CHOZN® cell lines, they immediately turned to Culture Biosciences’ services with cloud-connected bioreactors to optimize their bioprocess in real-time. Download this white paper to learn how MilliporeSigma: - Validated scale-up robustness - Generated significant increase in yield / titer for multiple CHOZN® cell lines - Validated results at scale #processdevelopment #processoptimization #CHO #mAb https://lnkd.in/eaDEmi2r

Interested in cell culture optimization. Learn more by downloading our whitepaper highlighting the Culture Biosciences collaboration with MilliporeSigma. #processoptimization #bioreactors #cloudconnectivity #bioprocess

𝐅𝐥𝐨𝐰 𝐂𝐲𝐭𝐨𝐦𝐞𝐭𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $10.3 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2032 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dgt4XySv The size of global flow cytometry market in terms of revenue was estimated to be worth $5.1 billion in 2024 and is poised to reach $10.3 billion by 2032, growing at a CAGR of 9.2% from 2024 to 2032. 𝐂𝐨𝐦𝐚𝐩𝐧𝐢𝐞𝐬 𝐩𝐫𝐨𝐟𝐢𝐥𝐞 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭: Becton, Dickinson and Company Danaher Corporation Thermo Fisher Scientific Agilent Technologies Bio-Rad Laboratories Miltenyi Biotec Enzo Biochem Inc Sysmex Corporation bioMérieux CYTONOME ST. LLC Sartorius Cytek Biosciences Union Biometrica, Inc. Takara Bio Inc. Apogee Flow Systems Stratedigm, Inc. NanoCellect Biomedical, Inc. On-chip Biotechnologies Co., Ltd Nexcelom BennuBio, Inc. ORFLO Technologies Bay Biosciences LLC. BioLegend CytoBuoy

Organ-On-Chip Market worth $631,073 thousand by 2029 Download PDF Brochure:-https://lnkd.in/d3NUir_P The size of global organ-on-chip market in terms of revenue was estimated to be worth $23,285 thousand in 2024 and is poised to reach $631,073 thousand by 2029, growing at a CAGR of 38.6% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 MIMETAS TissUse GmbH NETRI Emulate, Inc. CN BIO INNOVATIONS LIMITED InSphero SynVivo, Inc. AxoSim, Dynamic42 GmbH React4life Obatala Sciences AlveoliX Beonchip INITIO CELL Hesperos Inc., Lena Biosciences Revivocell Ltd. Altis Biosystems Biond Biologics Ltd BiomimX® Srl.R.L Cherry Biotech Fluigent Elveflow Microfluidics | an Elvesys brand #organonchip #bioengineering #biomedicalinnovation #tissueengineering #microfluidics

Flow Cytometry Market Worth $10.3 billion by 2032 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬: https://lnkd.in/drgvHfbd The size of global flow cytometry market in terms of revenue was estimated to be worth $5.1 billion in 2024 and is poised to reach $10.3 billion by 2032, growing at a CAGR of 9.2% from 2024 to 2032. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Becton, Dickinson and Company Danaher Corporation Thermo Fisher Scientific Agilent Technologies SONY CORPORATION Bio-Rad Laboratories Miltenyi Biotec Enzo Biochem Inc. Sysmex Corporation Cytek Biosciences bioMérieux CYTONOME ST. LLC Sartorius Union Biometrica, Inc. Takara Bio Inc. Apogee Flow Systems Stratedigm, Inc. NanoCellect Biomedical, Inc. BioLegend On-chip Biotechnologies Co., Ltd NEXCELOM BIOSCIENCE LTD. BennuBio, Inc. ORFLO Technologies Bay Biosciences LLC. CytoBuoy

#Article now available! Isolating CD4+ and CD8+ #Tcells for improved drug efficacy and increased productivity Isolating CD4+ and CD8+ T cell subsets is critical for controlling the ratio within a final drug product. It also has an impact on downstream steps such as #cryopreservation after isolation. In this article, Hany Meås (Staff Scientist, Thermo Fisher Scientific) explores a platform technology to enable the isolation of CD4+ and CD8+ T cells with an active release mechanism for either clinical or #commercialmanufacturing. Read below:

SFBN Feed: Multiply Labs and Fedegari Group Collaborate to Add Sterilization to Automated Cell Therapy Manufacturing for Eliminating Contamination Risks https://lnkd.in/gP3Q77fa SAN FRANCISCO–(BUSINESS WIRE)– #manufacturing–Multiply Labs and Fedegari Group collaborate to add sterilization to automated cell therapy manufacturing for eliminating contamination risks. Click here to view original post #BayArea #SanFrancisco #Biotech #Lifescience #News

Flow Cytometry Market worth $10.3 billion by 2032 Download PDF Brochure:-https://lnkd.in/dNqi2CjK The size of global flow cytometry market in terms of revenue was estimated to be worth $5.1 billion in 2024 and is poised to reach $10.3 billion by 2032, growing at a CAGR of 9.2% from 2024 to 2032. Top Key Players Becton, Dickinson and Company Danaher Corporation Thermo Fisher Scientific Agilent Technologies, Sony Bio-Rad Laboratories, Miltenyi Biotec Enzo Biochem Inc, Sysmex Corporation bioMérieux Cytonome Sartorius Cytek Biosciences Union Biometrica, Inc. Takara Bio USA, Inc. Apogee Flow Systems Stratedigm, Inc. NanoCellect Biomedical, Inc. On-chip Biotechnologies (USA), NEXCELOM BIOSCIENCE LTD. BennuBio, Inc. ORFLO Technologies Bay Biosciences LLC. BioLegend, CytoBuoy #flowcytometry #cellanalysis #biomedicalresearch #cytometry #biotech

Flow Cytometry Market worth $7.0 billion by 2028 Get Free Sample Pages :-https://lnkd.in/dZySzNkc The size of global flow cytometry market in terms of revenue was estimated to be worth $4.7 billion in 2023 and is poised to reach $7.0 billion by 2028, growing at a CAGR of 8.3% from 2023 to 2028. Top Key Players : BD , Danaher Corporation , Thermo Fisher Scientific, Agilent Technologies, Sony , Bio-Rad Laboratories, Miltenyi Biotec , Enzo Biochem Inc, Sysmex Corporation , bioMérieux , CYTONOME ST. LLC Sartorius , Cytek Biosciences, Union Biometrica, Inc. , Luminex ,  Apogee Flow Systems , Stratedigm, Inc. , NanoCellect Biomedical, Inc. , On-chip Biotechnologies (USA) , NEXCELOM BIOSCIENCE LTD. , BennuBio, Inc. , ORFLO Technologies , Bay Biosciences LLC. , BioLegend, CytoBuoy. #flowcytometry #healthcare #biotechnology #lifescience

Flow Cytometry Market worth $10.3 billion by 2032 Download PDF Brochure:-https://lnkd.in/dPg7RJHx The size of global flow cytometry market in terms of revenue was estimated to be worth $5.1 billion in 2024 and is poised to reach $10.3 billion by 2032, growing at a CAGR of 9.2% from 2024 to 2032. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Becton, Dickinson and Company Danaher Corporation Thermo Fisher Scientific Agilent Technologies, Sony Bio-Rad Laboratories, Miltenyi Biotec Enzo Biochem Inc. Sysmex Corporation bioMérieux Cytonome Sartorius Cytek Biosciences Union Biometrica, Inc. Takara Bio Inc. Apogee Flow Systems Stratedigm, Inc. NanoCellect Biomedical, Inc. On-chip Biotechnologies (USA), NEXCELOM BIOSCIENCE LTD. BennuBio, Inc. ORFLO Technologies Bay Biosciences LLC. BioLegend. CytoBuoy #flowcytometry #cytometry #cellanalysis #flowcytometrytech #cellsorting